Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 29;19(1):399.
doi: 10.1186/s12951-021-01150-6.

An overview and bibliometric analysis on the colorectal cancer therapy by magnetic functionalized nanoparticles for the responsive and targeted drug delivery

Affiliations
Review

An overview and bibliometric analysis on the colorectal cancer therapy by magnetic functionalized nanoparticles for the responsive and targeted drug delivery

Mahdieh Darroudi et al. J Nanobiotechnology. .

Abstract

With the growing demands for personalized medicine and medical devices, nanomedicine is a modern scientific field, and research continues to apply nanomaterials for therapeutic and damaged tissue diagnosis. In this regard, substantial progress has been made in synthesizing magnetic nanoparticles with desired sizes, chemical composition, morphologies, and surface chemistry. Among these materials, nanomagnetic iron oxides have demonstrated promise as unique drug delivery carriers due to cancer treatment. This carrier could lead to responsive properties to a specific trigger, including heat, pH, alternative magnetic field, or even enzymes, through functionalization and coating of magnetic nanoparticles, along with biocompatibility, good chemical stability, easy functionalization, simple processing, and ability to localize to the tumor site with the assistance of external magnetic field. Current studies have focused on magnetic nanoparticles' utilities in cancer therapy, especially for colorectal cancer. Additionally, a bibliometric investigation was performed on the public trends in the field of the magnetic nanoparticle to drug delivery and anticancer, which represented progressing applications of these carriers in the multidisciplinary zones with a general view on future research and identified potential opportunities and challenges. Furthermore, we outline the current challenges and forthcoming research perspective for high performance and fostering advanced MNPs in colorectal cancer treatment.

Keywords: Anticancer drugs; Bibliometric analysis; Colon cancer; Drug-delivery; Magnetic nanoparticles.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Use of Magnetic nanoparticles in medicine
Fig. 2
Fig. 2
Prisma flow diagram
Fig. 3
Fig. 3
a The network of keywords and b clustering of keywords during the time period
Fig. 4
Fig. 4
a Country collaboration map-related documents-published in the considered period, b three-field plot of top-author, top-countries; and top authors keywords on the considered topic
Fig. 5
Fig. 5
The most relevant affiliations on the considered topic
Fig. 6
Fig. 6
The most cited countries on considered topic, inset: the bibliometric analysis by subject area
Fig. 7
Fig. 7
a The plot of world growth of considered topic based on the subject, and b annual scientific publications sorted by publication years
Fig. 8
Fig. 8
Drug loading process on the magnetic NPs, stimuli sensitive release of drugs upon applying external stimuli and schematic illustration description the in vivo and in vitro nano combination therapy
Fig. 9
Fig. 9
Structure of 3 most common anticancer drugs 5-fluorouracil (5-FU), oxaliplatin, and irinotecan for colon cancer by magnetic nanoparticles
Fig. 10
Fig. 10
The timeline of magnetic nanoparticles in therapeutic and imaging application
Fig. 11
Fig. 11
Drug loading and sensitive release of drugs upon applying external stimuli
Fig. 12
Fig. 12
The schematic of prodrug 5-FC in drug delivery based on magnetic nanocarrier
Fig. 13
Fig. 13
The schematic representation of tumor treatment through stimuli sensitive release of drugs by magnetic nanocarrier and in vivo and in vitro

References

    1. Ulbrich K, Holá K, Šubr V, Bakandritsos A, Tuček J, Zbořil R. Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. Chem Rev. 2016 doi: 10.1021/acs.chemrev.5b00589. - DOI - PubMed
    1. Ma J, Jemal A, Fedewa SA, Islami F, Lichtenfeld JL, Wender RC, et al. The American Cancer Society 2035 challenge goal on cancer mortality reduction. CA Cancer J Clin. 2019;69:351–362. doi: 10.3322/caac.21564@10.3322/(ISSN)1542-4863.ACS_Cancer_Control_Blueprints. - DOI - PubMed
    1. Lammers T, Kiessling F, Hennink WE, Storm G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release. 2012;161:175–187. - PubMed
    1. Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target. 2016 doi: 10.3109/1061186X.2015.1051049. - DOI - PubMed
    1. Gupta PK. Drug targeting in cancer chemotherapy: a clinical perspective. J Pharm Sci. 1990;79(11):949–962. - PubMed

Substances